Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · ARS

International Stem Cell Corporation

ISCOOTCEQUITYCurrent

SEC Filing

Filed Apr 29, 2026Accepted Apr 29, 2026, 4:35 PM EDTCIK 1355790Accession 0001193125-26-191950
Share

Company context

Current securities

Recent company filings

  1. 4 filingSep 17, 2026
  2. Completion of Acquisition or Disposition of AssetsSep 8, 2026
  3. 10-Q filingAug 13, 2026
  4. DEF 14C filingAug 4, 2026
  5. PRE 14C filingJul 24, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗